Lexicon Pharmaceuticals (LXRX) Cost of Revenue (2017 - 2026)
Lexicon Pharmaceuticals (LXRX) reported Cost of Revenue of $108000.0 for Q1 2026, up 260.0% year-over-year from $30000.0 in Q1 2025, and down 46.27% quarter-over-quarter from $201000.0 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Cost of Revenue (2017 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 8 years of Cost of Revenue data on file, last reported at $108000.0 in Q1 2026.
- Cost of Revenue for Q1 2026 came in at $108000.0, up 260.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $352000.0 (down 42.76% YoY), and the FY2025 annual result was $274000.0, down 55.52% from the prior year.
- Cost of Revenue retreated to $108000.0 in Q1 2026 per LXRX's latest filing, from $201000.0 in the prior quarter.
- Over five years, Cost of Revenue peaked at $348000.0 in Q4 2024 and troughed at $7000.0 in Q3 2023.
- A 4-year average of $90250.0 and a median of $51500.0 in 2023 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2024 and 2025: Cost of Revenue jumped 1975.0% in 2024, then slumped 85.92% in 2025.
- A 4-year view of Cost of Revenue shows it stood at $70000.0 in 2023, then surged by 397.14% to $348000.0 in 2024, then sank by 42.24% to $201000.0 in 2025, then sank by 46.27% to $108000.0 in 2026.
- Business Quant data shows LXRX's Cost of Revenue at $108000.0 in Q1 2026, $201000.0 in Q4 2025, and $10000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 64.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 48,670.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 392.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 2.05 Mn |
| 10 | Lexicon Pharmaceuticals | 804.48 Mn | 633.82 Mn | 20.99 Mn | 108,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,000.00 |
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | 201,000.00 |
| Dec 31, 2025 | 201,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 33,000.00 |
| Jun 30, 2025 | 33,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Dec 31, 2024 | 348,000.00 |
| Dec 31, 2024 | 348,000.00 |
| Sep 30, 2024 | 71,000.00 |
| Sep 30, 2024 | 71,000.00 |
| Jun 30, 2024 | 166,000.00 |
| Jun 30, 2024 | 166,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Dec 31, 2023 | 70,000.00 |
| Dec 31, 2023 | 70,000.00 |